Article

2 Iconography
Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 63, n° 2
pages e58-e59 (août 2010)
Doi : 10.1016/j.jaad.2009.10.052
JAAD Online

Epidermal growth factor receptor inhibition with erlotinib for palmoplantar keratoderma
 

Brandi M. Kenner-Bell, MD a, Amy S. Paller, MD a, b, Mario E. Lacouture, MD a, b,
a Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois 
b Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois 

Reprint requests and correspondence: Mario E. Lacouture, MD, Dermatology Service, Memorial Sloan-Kettering Cancer Center, Rockefeller Outpatient Pavilion Suite 228, 160 East 53rd Street, New York, NY 10022

 Supported by a Zell Scholarship from the Robert H. Lurie Comprehensive Cancer Center and the Dermatology Foundation (to Dr Lacouture).
 Dr Lacouture is a speaker for Imclone Systems and a consultant for OSI and BMS. The other authors have no relevant financial conflicts of interest to disclose.


Top of the page

© 2010  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline
@@#110903@@